Iberdomide vs. Observation Post Ide-Cel CAR-T

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Near Add Your Location

Sorting 72 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Providence Oncology and Hematology - Eastside
Providence Cancer Institute Franz Clinic
Portland, OR
  • Accepting patients
Nebraska Medicine (Village Pointe)
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
UNC Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
  • Accepting patients
Memorial Sloan Kettering Commack
Commack, NY
  • Accepting patients
  • Show Principal Investigator
Aurora Cancer Care (Marinette)
Aurora Health
Marinette, WI
  • Accepting patients
Mission Cancer & Blood
Ankeny, IA
  • Accepting patients
Prisma Health Cancer Institute - Eastside
Eastside
Greenville, SC
  • Accepting patients
Medical Oncology and Hematology Associates-West Des Moines
Clive, IA
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.